Carl Eibl

Carl Eibl

Carl is the former Managing Director at Enterprise Partners, a San Diego-based, venture capital firm which at its height had $1billion under management. Prior to joining Enterprise in 2003, he was the CEO of several high profile technology and life science companies, including publicly-traded Maxwell Technologies (MXWL, NASDAQ), President of Stratagene Corporation (STGN), then a privately-held biotechnology company and CEO of Mycogen Corporation, a publicly-held agricultural, biotechnology company, acquired by Dow Chemical Company for $1.1 billion. Carl holds a J.D. from Boston University School of Law and a B.A. from Cornell University.